Goldman Sachs’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Sell
77,172
-70,981
-48% -$254K ﹤0.01% 6033
2026
Q1
$508K Sell
148,153
-111,383
-43% -$489K ﹤0.01% 5586
2025
Q4
$1.33M Buy
259,536
+122,089
+89% +$771K ﹤0.01% 4912
2025
Q3
$1.13M Buy
137,447
+93,075
+210% +$793K ﹤0.01% 4952
2025
Q2
$405K Buy
44,372
+7,928
+22% +$74.4K ﹤0.01% 5280
2025
Q1
$352K Buy
36,444
+10,573
+41% +$128K ﹤0.01% 5381
2024
Q4
$342K Buy
+25,871
New +$319K ﹤0.01% 5442
2024
Q3
Sell
-11,656
Closed -$142K 5799
2024
Q2
$142K Buy
+11,656
New +$156K ﹤0.01% 5344

Other funds holding ALVO

Goldman Sachs's ALVO Position: Q2 2026 in Review

Goldman Sachs reduced its Alvotech (ALVO) stake by 48% in Q2 2026, selling an estimated $254K and leaving 77,172 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #6033.

Goldman Sachs first reported a position in ALVO in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.33M in Q4 2025. 72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • Goldman Sachs held 77,172 shares of Alvotech worth $285K as of Q2 2026.
  • Goldman Sachs sold 70,981 Alvotech shares in Q2 2026, an estimated $254K.
  • Alvotech made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6033 holding.
  • Goldman Sachs first reported a position in Alvotech in Q2 2024 and has held it in 8 quarters since.
  • Goldman Sachs's Alvotech position peaked at $1.33M in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.